Prognostic and predictive value of FCER1G in glioma outcomes and response to immunotherapy

被引：0
作者：
Houshi Xu
Qingwei Zhu
Lan Tang
Junkun Jiang
Huiwen Yuan
Anke Zhang
Meiqing Lou
机构：
[1] Shanghai Jiao Tong University School of Medicine,Department of Neurosurgery, Shanghai General Hospital
[2] Zhejiang University,Department of Neurosurgery, Second Affiliated Hospital, School of Medicine
[3] Tongji University,undefined
来源：
Cancer Cell International | / 21卷
关键词：
Gliomas; Immunotherapy; T cell; FCER1G; biomarker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Prognostic value of a systemic inflammatory response index in metastatic renal cell carcinoma and construction of a predictive model
    Gu, Liangyou
    Ma, Xin
    Wang, Lei
    Li, Hongzhao
    Chen, Luyao
    Li, Xintao
    Zhang, Yu
    Xie, Yongpeng
    Zhang, Xu
    ONCOTARGET, 2017, 8 (32) : 52094 - 52103
  • [42] Prognostic Value of STK11 & KRAS Mutations and irAE Incidence in Response to Immunotherapy in Hispanics: A Multicenter Analysis
    Basher, F.
    Raez, L.
    Saravia, D.
    Rodriguez, E.
    Uba, R.
    Arora, A.
    Ocejo, J.
    Khan, K.
    Meiyappan, K.
    Dvir, K.
    Fortuna, G. Galarza
    North, A.
    Dumais, K.
    Powery, H.
    Izquierdo, P.
    De Lima Lopes, G.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S888 - S888
  • [43] HMGA1 Has Predictive Value in Response to Chemotherapy in Gastric Cancer
    Padua, Diana
    Pinto, Debora Filipa
    Figueira, Paula
    Pereira, Carlos Filipe
    Almeida, Raquel
    Mesquita, Patricia
    CURRENT ONCOLOGY, 2022, 29 (01) : 56 - 67
  • [44] Exploring GZMK as a prognostic marker and predictor of immunotherapy response in breast cancer: unveiling novel insights into treatment outcomes
    Li, Zitao
    Xie, Qiqi
    Zhao, Fuxing
    Huo, Xinfa
    Ren, Dengfeng
    Liu, Zhilin
    Zhou, Xiaofeng
    Shen, Guoshuang
    Zhao, Jiuda
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (06)
  • [45] Predictive and prognostic value of EPIC1 in patients with breast cancer receiving neoadjuvant chemotherapy
    Xu, Yaqian
    Wang, Yan
    Yuan, Chenwei
    Sheng, Xiaonan
    Sha, Rui
    Dai, Huijuan
    Zhang, Shan
    Wang, Yaohui
    Lin, Yanping
    Zhou, Liheng
    Xu, Shuguang
    Zhang, Jie
    Yin, Wenjin
    Lu, Jinsong
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [46] Prognostic and predictive value of neutrophil-to-lymphocyte ratio with adjuvant immunotherapy in stage III non-small-cell lung cancer
    Bryant, Alex K. K.
    Sankar, Kamya
    Strohbehn, Garth W. W.
    Zhao, Lili
    Elliott, David
    Qin, Angel
    Yentz, Sarah
    Ramnath, Nithya
    Green, Michael D. D.
    LUNG CANCER, 2022, 163 : 35 - 41
  • [47] Value of long non-coding RNA HAS2-AS1 as a diagnostic and prognostic marker of glioma
    You, A.
    Gu, J.
    Wang, J.
    Li, J.
    Zhang, Y.
    Rao, G.
    Ge, X.
    Zhang, K.
    Gao, X.
    Wang, D.
    NEUROLOGIA, 2024, 39 (04): : 353 - 360
  • [48] Prognostic potential of m7G-associated lncRNA signature in predicting bladder cancer response to immunotherapy and chemotherapy
    Li, Deng-xiong
    Wu, Rui-cheng
    Wang, Jie
    Feng, De-chao
    Deng, Shi
    ONCOLOGIE, 2023, 25 (06) : 729 - 742
  • [49] Programmed Cell Death Ligand 1 in Breast Cancer: Technical Aspects, Prognostic Implications, and Predictive Value
    Miglietta, Federica
    Griguolo, Gaia
    Guarneri, Valentina
    Dieci, Maria Vittoria
    ONCOLOGIST, 2019, 24 (11) : E1055 - E1069
  • [50] The clinicopathological significance and predictive value for immunotherapy of programmed death ligand-1 expression in Epstein-Barr virus-associated gastric cancer
    Wei, Xiao-Li
    Liu, Qian-Wen
    Liu, Fu-Rong
    Yuan, Sha-Sha
    Li, Xiao-Fen
    Li, Jia-Ning
    Yang, An-Li
    Ling, Yi-Hong
    ONCOIMMUNOLOGY, 2021, 10 (01):
12345